Skip to content

How body tissue massage may help women with severe menstrual cramps

Effects of connective tissue manipulation in the treatment of women with primary dysmenorrhea: A clinical trial, double-blinded, placebo-controlled

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7wzpzfr
Enrollment
46
Registered
2026-03-05
Start date
2024-05-27
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea Menstruation disturbances

Interventions

This is a two arm double blind randomized controlled clinical trial Experimental group composed of 23 women with primary dysmenorrhea who will receive Connective Tissue Manipulation sessions applied t

Sponsors

Centro de Ciências Biológicas e da Saúde
Lead Sponsor
Universidade Federal de São Carlos
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Nulliparous women; aged 18 to 35 years; regular menstrual cycle; menstruated in the last 30 days; complaints of menstrual cramps; abdominal or pelvic pain before or during menstruation with intensity = 4 on the Numeric Pain Rating Scale; pain onset 6 to 12 months after menarche

Exclusion criteria

Exclusion criteria: History of recent menstrual pain (<1 year); pregnant or suspected pregnancy; body mass index (BMI) above 32; use of any intrauterine device; history or diagnosis of secondary dysmenorrhea; use of oral contraceptives or antidepressants; suspected pregnancy during the study; confirmed pregnancy during the study; suspected or diagnosed secondary dysmenorrhea during the study

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be the intensity of menstrual pain during the first 3 days of the cycle, assessed before and after the intervention.

Secondary

MeasureTime frame
Secondary outcomes will be the occurrence of menstrual symptoms and medication use in the first 3 days of the cycle, assessed before and after the intervention.

Countries

BR

Contacts

Public ContactGiovanna Mansão

Universidade Federal de São Carlos

giovannaramos@estudante.ufscar.br+55 16 993096126

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Apr 4, 2026